Ed Lemmens
Ed Lemmens publishes mostly in Oncology, Immunology and Biotechnology, on topics such as Cancer Research and Treatments, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.
- World rank
- #2,251,379 of 7,710,434 ranked researchers
- Rank in United States
- #673,511 of 1,627,098
- Works
- 56
- Citations
- 988
- Citations per work
- 17.6
What does Ed Lemmens research?
Ed Lemmens's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2545.1%
- Medicine2545.1%
- Life Sciences2036.6%
- Everything else814.1%
- Physical Sciences24.2%
- Engineering24.2%
- 1Oncology34% of their works
- 2Immunology18% of their works
- 3Biotechnology18% of their works
- 4Pulmonary and Respiratory Medicine8% of their works
- 5Biomedical Engineering4% of their works
- 6Hematology3% of their works
Research topics
Which keywords describe Ed Lemmens's research?
The keywords of their largest research topics: Immunotherapy, Tumor Regression, Gene Therapy, Tumor Microenvironment, Bacterial Therapy, Cancer Immunotherapy, Tumor Targeting and Dendritic Cells.
- Natural Killer Cells
- AAV
- BAP1 mutations
- CAR T Cells
- Pancreatic Cancer
- Immunity
- Dendritic Cells
- Cancer Immunotherapy
- Tumor Microenvironment
- Tumor Regression
- Immunotherapy
- Gene Therapy
- Bacterial Therapy
- Tumor Targeting
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Surgical Complications
- Chimeric Antigen Receptor
- Malignant Pleural Mesothelioma
- NK Cell Recognition
- Viral Vectors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Immunotherapy274 topics
- Tumor Regression182 topics
- Gene Therapy152 topics
- Tumor Microenvironment142 topics
- Bacterial Therapy131 topic
- Cancer Immunotherapy132 topics
- Tumor Targeting131 topic
- Dendritic Cells81 topic
- Immune Checkpoint Blockade81 topic
- Immunity81 topic
- PD-1 and PD-L181 topic
- Pancreatic Cancer61 topic
- Surgical Complications61 topic
- CAR T Cells51 topic
- Chimeric Antigen Receptor51 topic
- BAP1 mutations31 topic
- Malignant Pleural Mesothelioma31 topic
- AAV21 topic
- NK Cell Recognition21 topic
- Natural Killer Cells21 topic
- Viral Vectors21 topic
Where does Ed Lemmens work?
Ed Lemmens's main affiliation in the publication record is Aduro BioTech (United States), United States.
How many publications and citations does Ed Lemmens have?
OpenAlex counts 56 works and 988 citations for Ed Lemmens, an h-index of 9, ranking #2,251,379 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ed Lemmens. Posts are plain text and can be reported.